Performance of urinary NT-proBNP in ambulatory settings

被引:2
|
作者
Mueller, Nicole [1 ]
Bayer, Eva [1 ]
Bernhardt, Christine [1 ]
Breuer, Johannes [1 ]
Freudenthal, Noa J. [1 ]
机构
[1] Univ Bonn, Childrens Hosp, Dept Pediat Cardiol, Venusberg Campus 1, D-53127 Bonn, Germany
关键词
Urinary NT-proBNP; Congenital heart disease; Ambulatory setting; Ross-classification; Follow up; CONGENITAL HEART-DISEASE; BRAIN NATRIURETIC PEPTIDE; CLINICAL UTILITY; DIAGNOSTIC-VALUE; CARDIAC-DISEASE; CHILDREN; MANAGEMENT; FAILURE; SERUM; BNP;
D O I
10.1016/j.cca.2022.01.025
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: NT-proBNP (N-terminal prohormone of brain natriuretic peptide) has been established as a useful biomarker in plasma for children with congenital heart disease (CHD). Plasma values were shown to correlate well with urinary values. We designed a study to investigate the general utility of urinary NT-proBNP in children with and without CHD in an ambulatory setting. Material and methods: 202 children (mean age 93 months (1-225 months)) were included in the analysis. We investigated the performance of urinary NT-proBNP values determined from spot urine as a diagnostic tool for different forms of congenital heart disease. Results: Urinary NT-proBNP is a good diagnostic tool for children with congenital heart disease (ROC area under the curve 0.807). Combining these values with the Ross-classification further improves the diagnostic power (ROC area under the curve 0.831) Analysis also showed significant differences between Lg(10) urinary NT-proBNP values of healthy controls and those of children after corrective surgery. Furthermore, children who have completed the stages of Fontan palliation showed higher values than age matched controls. Conclusions: Urinary NT-proBNP can be used in an ambulatory setting to discriminate between relevant and nonrelevant CHD and might be valuable as a follow up parameter for children after biventricular repair or univentricular palliation. Age dependant urinary NT-proBNP normal values for children could be an easy-to-use tool for general practitioners as well as specialised clinics.
引用
收藏
页码:4 / 9
页数:6
相关论文
共 50 条
  • [21] The biomarkers BNP and NT-proBNP
    Oremek, G. M.
    Passek, K.
    Holzgreve, F.
    von der Eltz, V.
    Droege, J.
    ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE, 2023, 73 (02): : 89 - 95
  • [22] Urinary values of NT-proBNP in children with congenital heart disease - Is it feasible?
    Mueller, Nicole
    Rothkegel, Stefanie T.
    Boerter, Nicolas
    Breuer, Johannes
    Freudenthal, Noa J.
    CLINICA CHIMICA ACTA, 2020, 509 : 224 - 227
  • [23] Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus
    S S Khan
    T Sithisarn
    H S Bada
    M Vranicar
    P M Westgate
    M Hanna
    Journal of Perinatology, 2017, 37 : 1319 - 1324
  • [24] URINARY NT-PROBNP LEVELS AND ECHOCARDIOGRAPHIC PARAMETERS FOR PATENT DUCTUS ARTERIOSUS
    Khan, S. S.
    Thitinart, S.
    Bada, H.
    Vranicar, M.
    Hanna, M.
    Li, Y.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 418 - 418
  • [25] Does urinary NT-proBNP have a role in predicting bronchiolitis severity?
    Rajvanshi, Nikhil
    Kalyana, Prabhakaran B.
    Kumar, Prawin
    Goyal, Jagdish P.
    PEDIATRIC PULMONOLOGY, 2023, 58 (09) : 2462 - 2463
  • [26] Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus
    Khan, S. S.
    Sithisarn, T.
    Bada, H. S.
    Vranicar, M.
    Westgate, P. M.
    Hanna, M.
    JOURNAL OF PERINATOLOGY, 2017, 37 (12) : 1319 - 1324
  • [27] Lower Urinary NT-proBNP Excretion in Patients with Chronic Heart Failure
    Linssen, Gerand C.
    Damman, Kevin
    Voors, Adriaan A.
    Hillege, Hans L.
    Navis, Gerjan
    van Veldhuisen, Dirk J.
    CIRCULATION, 2008, 118 (18) : S1036 - S1036
  • [28] LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
    Antonio, Maria
    Vitorino, Rui
    Daniel-da-Silva, Ana L.
    BIOSENSORS-BASEL, 2023, 13 (07):
  • [29] Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform
    Hammerer-Lercher, Angelika
    Griesmacher, Andrea
    Poelzl, Gerhard
    Brinskelle-Schmal, Natascha
    Mair, Johannes
    Frick, Matthias
    Hawa, Gerhard
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (10) : 1305 - 1308
  • [30] Early NT-proBNP Decrease With Ivabradine in Ambulatory Patients With Systolic Heart Failure
    Sargento, Luis
    Satendra, Milan
    Longo, Susana
    Lousada, Nuno
    dos Reis, Roberto Palma
    CLINICAL CARDIOLOGY, 2013, 36 (11) : 677 - 682